Víctor Celemín Capaldi

Ageing is characterised by the accumulation of cellular damage. Among the biomarkers associated with this process are epigenetic ‘clocks’, which analyse non-genetic modifications of DNA over time. However, these approaches have certain limitations, as they do not reflect the activity of specific genes. Now, a study published in Nature has analysed more than 11,000 transcriptomes from over 25 tissues in mice, rats, macaques and humans, showing that ageing-associated changes are conserved across species and cell types. The findings reveal universal transcriptomic signatures of ageing and mortality in mammals. Using these data, the authors developed their own molecular ‘clocks’, capable of estimating biological age and expected mortality.

A clinical trial (COSMOS) involving 958 healthy adults with an average age of 70 tested the ability of a multivitamin supplement, together with cocoa extract, to slow ageing. The results, published in Nature Medicine, show that the supplement slightly slowed two of the five biological markers of ageing measured after two years of daily use. The two markers affected were PCPhenoAge and PCGrimAge, whose rate of increase was reduced by 2.6 months and 1.4 months respectively. The slowing effect was greater among participants who initially showed more accelerated ageing. Cocoa showed no effect.